We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
Cap. Flow
+$273M
Cap. Flow %
5.31%
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$28.6M
2
AGN
Allergan plc
AGN
+$26.5M
3
TTC icon
Toro Company
TTC
+$22.4M
4
PEP icon
PepsiCo
PEP
+$20.4M
5
LMT icon
Lockheed Martin
LMT
+$17.5M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$26.1M
2
WFC icon
Wells Fargo
WFC
+$19.4M
3
CNC icon
Centene
CNC
+$17.3M
4
LLY icon
Eli Lilly
LLY
+$15.8M
5
KR icon
Kroger
KR
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Financials 18.08%
3 Industrials 12.96%
4 Healthcare 11.05%
5 Consumer Discretionary 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAI
801
DELISTED
CAI International, Inc.
CAI
$278K 0.01%
+9,160
New +$253K
LGF.A
802
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$277K 0.01%
8,290
-23,602
-74% -$695K
EGIO
803
DELISTED
Edgio, Inc. Common Stock
EGIO
$276K 0.01%
1,737
-12
-0.7% -$1.69K
ARRY
804
DELISTED
Array Biopharma Inc
ARRY
$276K 0.01%
+22,460
New +$209K
MRTX
805
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$275K 0.01%
23,500
+12,300
+110% +$71.2K
PCRX icon
806
Pacira BioSciences
PCRX
$1.02B
$273K 0.01%
+7,280
New +$293K
LEAF
807
DELISTED
Leaf Group Ltd.
LEAF
$271K 0.01%
39,315
-2,200
-5% -$15.7K
KPTI icon
808
Karyopharm Therapeutics
KPTI
$168M
$270K 0.01%
1,640
+760
+86% +$109K
MNST icon
809
Monster Beverage
MNST
$91.4B
$269K 0.01%
9,740
-2,560
-21% -$69K
IO
810
DELISTED
ION Geophysical Corporation
IO
$269K 0.01%
28,284
-12,704
-31% -$76.7K
EZPW icon
811
Ezcorp Inc
EZPW
$1.82B
$268K 0.01%
28,200
-200
-0.7% -$1.75K
PCH
812
DELISTED
PotlatchDeltic
PCH
$265K 0.01%
+5,200
New +$246K
HAE icon
813
Haemonetics
HAE
$3.58B
$263K 0.01%
+5,860
New +$243K
BUSE icon
814
First Busey Corp
BUSE
$2.52B
$260K 0.01%
8,299
– –
BOKF icon
815
BOK Financial
BOKF
$8.64B
$258K 0.01%
2,900
-3,440
-54% -$287K
INCY icon
816
Incyte
INCY
$23.5B
$258K 0.01%
+2,210
New +$280K
SEAC
817
DELISTED
Seachange International Inc
SEAC
$258K 0.01%
4,716
-649
-12% -$35K
EPZM
818
DELISTED
Epizyme, Inc
EPZM
$255K 0.01%
+13,390
New +$204K
ACM icon
819
Aecom
ACM
$9.07B
$254K ﹤0.01%
6,910
+600
+10% +$19.7K
MXWL
820
DELISTED
Maxwell Technologies Inc
MXWL
$254K ﹤0.01%
49,514
-41,400
-46% -$236K
LTXB
821
DELISTED
LegacyTexas Financial Group Inc
LTXB
$246K ﹤0.01%
6,150
– –
SAFE
822
Safehold
SAFE
$1.19B
$244K ﹤0.01%
+4,242
New +$244K
HTB
823
HomeTrust Bancshares
HTB
$818M
$243K ﹤0.01%
+9,480
New +$226K
MIK
824
DELISTED
Michaels Stores, Inc
MIK
$243K ﹤0.01%
11,300
-29,700
-72% -$605K
FBNK
825
DELISTED
First Connecticut Bancorp, Inc
FBNK
$241K ﹤0.01%
+9,015
New +$229K
31 32
33
34 35

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q3 2017 Portfolio in Review

As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
  • Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
  • Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
  • Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
  • Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
  • Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.